CHILDREN'S DIMETAPP COLD & ALLERGY CHEWABLE TABLETS OTC
Generic Name and Formulations:
Brompheniramine maleate 1mg, phenylephrine HCl 2.5mg; per tab; alcohol-free; grape flavor.
Pfizer Consumer Healthcare
Indications for CHILDREN'S DIMETAPP COLD & ALLERGY CHEWABLE TABLETS:
Rhinorrhea, allergy symptoms, nasal congestion.
<6yrs: do not use. 6–11yrs: chew 2 tabs every 4 hours; max 6 doses/24 hours.
Children <6yrs old. During or within 14 days of MAOIs. For use as a sedative hypnotic.
Hypertension. Cardiovascular disease. Thyroid disease. Diabetes. Glaucoma. GI or GU obstruction. Asthma. Lower respiratory disorders. Pregnancy. Nursing mothers.
Antihistamine + sympathomimetic.
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase pressor effects of sympathomimetics. Antihypertensives antagonized. Increased CNS effects with other CNS depressants. Avoid alcohol.
Drowsiness, anticholinergic effects, dizziness, nervousness, insomnia, excitability in children.
Syrup—4oz, 8oz (w. dosing cup)
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Differences in Efficacy and Tolerability of ADHD Medications Across Age Groups
- Associations Between Hypovitaminosis D and Poorer Outcomes in Schizophrenia
- Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
- Comorbid Narcolepsy and Schizophrenia in Adolescents
- Ketamine in Electroconvulsive Therapy Accelerates Antidepressive Effects
- Quetiapine Exposure Does Not Appear to Increase Risk for Infant Malformations
- Selective Serotonin Reuptake Inhibitors May Increase Risk for Suboptimal Fetal Growth
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Prenatal Insecticide Exposure in Mother May Be Linked to Risk for Autism in Children